Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
News about Tenet Healthcare Corporation (NYSE: THC) centers on its role as a diversified healthcare services company with operations in general medical and surgical hospitals, ambulatory surgery centers, and healthcare business services. Tenet is headquartered in Dallas and regularly issues press releases and SEC-related announcements that provide insight into its hospital and ambulatory performance, capital structure, and strategic priorities.
Investors and healthcare observers following Tenet’s news can expect detailed quarterly earnings releases that discuss results for its Ambulatory segment, anchored by United Surgical Partners International, and its Hospital Operations and Services segment. These updates often highlight same-facility or same-hospital revenue trends, case mix, acuity, payer mix, and segment-level Adjusted EBITDA, along with commentary on operational discipline and focus areas such as higher acuity services.
Tenet’s news flow also includes announcements about upcoming earnings release dates and conference calls, participation in healthcare conferences, and descriptions of its mission to deliver quality, compassionate care. In addition, the company issues press releases related to financing activities, such as private offerings of senior secured first lien notes and senior notes used to refinance existing indebtedness, and other capital markets transactions that are later reflected in Form 8-K filings.
Sector-specific updates can feature collaborations and sponsorships that relate to clinical specialties, such as orthopaedics through partnerships involving Tenet and United Surgical Partners International. For anyone tracking THC stock, this news page provides a centralized view of Tenet’s public communications, from financial results and outlook commentary to strategic initiatives, governance developments and capital structure actions.
Summary not available.
Tenet Healthcare Corporation (NYSE: THC) anticipates exceeding the midpoint of its FY22 Adjusted EBITDA Outlook, projected at $3.425 billion, despite not finalizing all financials. CEO Saum Sutaria highlighted strong management capabilities across all business units. Leadership updates include the retirement of key executives, with ongoing searches for successors. Daniel Cancelmi and Brett Brodnax will retire at the end of 2023, while Roger Davis will step down in Q1 2023. New promotions within operational leadership aim to enhance strategic execution and operational consistency, reinforcing Tenet's commitment to performance.
Tenet Healthcare Corporation (NYSE: THC) is set to release its fourth quarter 2022 results on February 9, 2023, by 6:00 a.m. Central Time. This will be followed by a conference call at 9:00 a.m. CT. Investors can access a live webcast and audio archive of the call through the investor relations section of Tenet's website.
Headquartered in Dallas, Tenet's extensive healthcare network includes over 465 ambulatory surgery centers, 61 acute care hospitals, and Conifer Health Solutions for revenue cycle management. The company is committed to providing quality healthcare in the communities it serves.
Tenet Healthcare Corporation (NYSE: THC) will present at the BofA Securities 2022 Leveraged Finance Conference on November 29, 2022, at 8:10 a.m. Eastern time. Investors can access the live webcast and audio archive through Tenet's investor relations website, with a replay available for 30 days post-event.
Headquartered in Dallas, Tenet operates a diverse healthcare network, including over 465 ambulatory surgery centers, 61 hospitals, and various outpatient facilities, aiming to deliver quality care in the communities served.
Tenet Healthcare Corporation (NYSE: THC) will present at the Credit Suisse 31st Annual Healthcare Conference on November 8, 2022, at 11:00 a.m. Eastern time. Investors can access a live webcast and audio archive through the investor relations section of Tenet's website, where the replay will be available for 30 days. Based in Dallas, Tenet operates a diverse healthcare network, including over 465 ambulatory surgery centers and 61 acute care hospitals. Through its Conifer Health Solutions subsidiary, the company provides revenue cycle management and value-based care services.
Tenet Healthcare reported a net income of $131 million in Q3 2022, translating to $1.16 per diluted share, down significantly from $448 million in Q3 2021. Adjusted diluted EPS decreased to $1.44. Consolidated Adjusted EBITDA was $841 million, a slight decline from $855 million year-over-year. The company announced a $1 billion share repurchase program to enhance shareholder value and revised its FY 2022 Adjusted EBITDA outlook to a range of $3.375 billion to $3.475 billion.
While USPI saw a 16.4% EBITDA growth, hospital admissions dropped by 5.3% reflecting pandemic pressures.
Tenet Healthcare Corporation (NYSE: THC) will announce its third quarter results on October 20, 2022, after market close. A conference call is scheduled for October 21, 2022, at 10:00 a.m. Eastern time. Interested parties can access the live webcast and audio archive via the company’s investor relations website. Tenet operates a vast care network, including over 465 ambulatory surgery centers and 61 acute and specialty hospitals, aiming to provide quality healthcare services across various communities.
Destination Pet announces the appointment of Dr. Jennifer Strickland Fowler as its new Chief Executive Officer effective August 1, 2022. Dr. Fowler, formerly the Chief Operating Officer at Tenet Physician Resources, is expected to lead the company through its next growth phase. Her extensive experience includes enhancing operations and growth at Millennium Health. Destination Pet operates across 23 states and offers integrated pet and medical care services.
Tenet Healthcare Corporation (THC) reported Q2 2022 net income of $38 million, down from $120 million in Q2 2021. Adjusted EBITDA rose to $843 million, slightly up from $834 million year-over-year. Diluted earnings per share dropped to $0.35 from $1.11 in Q2 2021. A cybersecurity incident negatively impacted adjusted admissions by 5.3%. The acquisition of USPI's remaining 5% stake cost $406 million. Tenet reaffirmed its FY 2022 Adjusted EBITDA outlook at $3.375 billion to $3.575 billion, despite a significant debt refinancing, reducing future annual interest payments by $61 million.
Tenet Healthcare Corporation (NYSE: THC) will report its second-quarter results for the period ending June 30, 2022, after market close on July 21, 2022. A conference call is scheduled for July 22, 2022, at 10:00 a.m. Eastern time, accessible via a live webcast on Tenet's investor relations page.
Tenet operates a comprehensive healthcare network, including approximately 440 ambulatory surgery centers, 60 acute care hospitals, and a subsidiary, Conifer Health Solutions, which offers revenue cycle management services.